Coherus Biosciences | CHRS - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 444.6B 59.91B 2026-06
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Amgen USD 195.44B 5.55B 2026-06
Baxter International USD 11.01B 2.34B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.13T 260.54B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
Merck USD 317.37B 20.27B 2026-06
Pacira USD 998M 83M 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06
Xencor USD 1.19B 301M 2026-06
Zoetis USD 30.13B 19.58B 2026-06